Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors

被引:68
作者
Castilho, MS
Postigo, MP
de Paula, CBV
Montanari, CA
Oliva, G
Andricopulo, AD
机构
[1] Univ Sao Paulo, Lab Quim Med & Computac, Ctr Biotecnol Mol Estrutural, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil
[2] Univ Fed Minas Gerais, NEQUIM, BR-31270901 Belo Horizonte, MG, Brazil
基金
巴西圣保罗研究基金会;
关键词
QSAR; CoMFA; CoMSIA; HQSAR; PNP; inhibitors;
D O I
10.1016/j.bmc.2005.08.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Comparative molecular field analysis (CoMFA), comparative molecular similarity indices analysis, and hologram quantitative structure-activity relationship (HQSAR) studies were conducted on a series of 52 training set inhibitors of calf spleen purine nucleoside phosphorylase (PNP). Significant cross-validated correlation coefficients (CoMFA, q(2) = 0.68; COMSIA, q(2) = 0.66; and HQSAR, q(2) = 0.70) were obtained, indicating the potential of the models for untested compounds. The models were then used to predict the inhibitory potency of 16 test set compounds that were not included in the training set, and the predicted values were in good agreement with the experimental results. The final QSAR models along with the information gathered from 3D contour and 2D contribution maps should be useful for the design of novel inhibitors of PNP having improved potency. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:516 / 527
页数:12
相关论文
共 27 条
[1]   Structure-activity relationships for a collection of structurally diverse inhibitors of purine nucleoside phosphorylase [J].
Andricopulo, AD ;
Yunes, RA .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (01) :10-17
[2]  
ANU JT, 2004, J CHEM INF COMP SCI, V44, P807
[3]   Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies [J].
Avery, MA ;
Alvim-Gaston, M ;
Rodrigues, CR ;
Barreiro, EJ ;
Cohen, FE ;
Sabnis, YA ;
Woolfrey, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :292-303
[4]  
Bantia S, 2004, CURR OPIN DRUG DISC, V7, P243
[5]   Guanine, pyrazolo[3,4-d] pyrimidine, and triazolo[4,5-d] pyrimidine (8-azaguanine) phosphonate acyclic derivatives as inhibitors of purine nucleoside phosphorylase [J].
Beauchamp, LM ;
Tuttle, JV ;
Rodriguez, ME ;
Sznaidman, ML .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) :949-956
[6]   Purine nucleoside phosphorylases: properties, functions, and clinical aspects [J].
Bzowska, A ;
Kulikowska, E ;
Shugar, D .
PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) :349-425
[7]   Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase [J].
Farutin, V ;
Masterson, L ;
Andricopulo, AD ;
Cheng, JM ;
Riley, B ;
Hakimi, R ;
Frazer, JW ;
Cordes, EH .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) :2422-2431
[8]   STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE .4. A STUDY OF PHOSPHATE MIMICS [J].
GUIDA, WC ;
ELLIOTT, RD ;
THOMAS, HJ ;
SECRIST, JA ;
BABU, YS ;
BUGG, CE ;
ERION, MD ;
EALICK, SE ;
MONTGOMERY, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) :1109-1114
[9]   Fluorophosphonate derivatives of N-9-benzylguanine as potent, slow-binding multisubstrate analogue inhibitors of purine nucleoside phosphorylase [J].
Halazy, S ;
Ehrhard, A ;
Eggenspiller, A ;
BergesGross, V ;
Danzin, C .
TETRAHEDRON, 1996, 52 (01) :177-184
[10]   Computational studies on HIV-1 protease inhibitors: Influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models [J].
Jayatilleke, PRN ;
Nair, AC ;
Zauhar, R ;
Welsh, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4446-4451